Reduction in platelet reactivity with prasugrel 5 mg in low-body-weight patients is noninferior to prasugrel 10 mg in higher-body-weight patients: results from the FEATHER trial - Erlinge, D; ten Berg, J; Foley, D (J Am Coll Cardiol, 2012)